Please share:
By
Florian Stigler (MD, DrPH, MPH)
The case report from the NEJM:
Disclaimer: This site and its related services are for informational purposes only and do not provide medical advice. The use of any information provided is solely at your own risk. Neither the site owner nor site contributors can accept responsibility for any loss, damage or injury that arises from the use of this website or services. More information here.
Essential Updates
“exciting, practical, evidence-based, short”
2-min reads by & for GPs.
Free, no pharma money.
The long-awaited 23-year results of the European Prostate Cancer Screening Study (ERSPC) are finally here. PSA screening saves about 2 lives per 1,000 men but leads to 27 extra diagnoses—highlighting …
A 15-year RCT found no survival difference between monitoring, surgery, or radiotherapy for localized prostate cancer, but notable trade-offs in disease progression and treatment-related side effects. Careful decision-making and risk …
I am convinced GPs are the backbone of effective healthcare systems. Here you can find an easy-to-read review of the evidence – which undoubtedly supports this claim!
<div class="likebtn_container" …Lecanemab, a new Alzheimer’s drug, recently gained EMA approval. But how effective is it really, considering the data shows only modest cognitive decline reduction and significant side effects like brain …
As demand is high and availability is low: which patients should get GLP-analogs first? What are the true benefits and side effects? Here you can find everything you need to …
